Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847.
D'Agostino RB, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001, 286: 180-7.
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, et al: European guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2004, 173: 379-389.
Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Sorlie P, Diao G, et al: An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Archives of internal medicine. 2006, 166: 1368-1373. 10.1001/archinte.166.13.1368.
Ridker PM, Buring JE, Rifai N, Cook NR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007, 297: 611-619. 10.1001/jama.297.6.611.
Assmann G, Cullen P, Schulte H: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002, 105: 310-315. 10.1161/hc0302.102575.
Palomaki GE, Melillo S, Bradley LA: Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA. 2010, 303: 648-656. 10.1001/jama.2010.118.
Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E: Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circulation. Cardiovascular genetics. 2009, 2: 279-285. 10.1161/CIRCGENETICS.108.817338.
Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, Humphries SE: Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clinical chemistry. 2008, 54: 467-474. 10.1373/clinchem.2007.095489.
Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM: Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21. 3. Annals of internal medicine. 2009, 150: 65-72.
Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, et al: Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. Journal of the American College of Cardiology. 2008, 51: 435-443. 10.1016/j.jacc.2007.05.057.
Bare LA, Morrison AC, Rowland CM, Shiffman D, Luke MM, Iakoubova OA, Kane JP, Malloy MJ, Ellis SG, Pankow JS, et al: Five common gene variants identify elevated genetic risk for coronary heart disease. Genetics in medicine. 2007, 9: 682-689. 10.1097/GIM.0b013e318156fb62.
Shiffman D, O'Meara ES, Bare LA, Rowland CM, Louie JZ, Arellano AR, Lumley T, Rice K, Iakoubova OA, Luke MM, et al: Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arteriosclerosis, thrombosis, and vascular biology. 2008, 28: 173-179. 10.1161/ATVBAHA.107.153981.
Shiffman D, Chasman DI, Zee RYL, Iakoubova OA, Louie JZ, Devlin JJ, Ridker PM: A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. Journal of the American College of Cardiology. 2008, 51: 444-448. 10.1016/j.jacc.2007.09.044.
Stewart AFR, Dandona S, Chen L, Assogba O, Belanger M, Ewart G, LaRose R, Doelle H, Williams K, Wells GA, et al: Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. Journal of the American College of Cardiology. 2009, 53: 1471-1472. 10.1016/j.jacc.2008.12.051.
Assimes TL, Hólm H, Kathiresan S, Reilly MP, Thorleifsson G, Voight BF, Erdmann J, Willenborg C, Vaidya D, Xie C, et al: Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. Journal of the American College of Cardiology. 2010, 56: 1552-1563. 10.1016/j.jacc.2010.06.022.
Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U: Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. Journal of internal medicine. 2002, 252: 247-254. 10.1046/j.1365-2796.2002.01029.x.
Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A: The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991, 1: 263-276. 10.1016/1047-2797(91)90005-W.
Buckley DI, Fu R, Freeman M, Rogers K, Helfand M: C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the US Preventive Services Task Force. Annals of internal medicine. 2009, 151: 483-495.
Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Annals of epidemiology. 1993, 3: 358-366. 10.1016/1047-2797(93)90062-9.
Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Health Study. Clinical chemistry. 1995, 41: 264-70.
Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events: The Cardiovascular Health Study. Annals of Epidemiology. 1995, 5: 278-285. 10.1016/1047-2797(94)00093-9.
Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Annals of Epidemiology. 1995, 5: 270-277. 10.1016/1047-2797(94)00092-8.
Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in medicine. 2008, 27: 157-172. 10.1002/sim.2929.
StataCorp: Stata Statistical Software: Release 9. 2005
Hlatky a, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, Go AS, Harrell FE, Hong Y, Howard BV, et al: Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009, 119: 2408-2416. 10.1161/CIRCULATIONAHA.109.192278.
Schnell-Inderst P, Schwarzer R, Göhler A, Grandi N, Grabein K, Stollenwerk B, Manne J, Klauss V, Siebert U, Wasem J: Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. International journal of technology assessment in health care. 2010, 26: 30-39. 10.1017/S0266462309990870.
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology. 2004, 159: 882-890. 10.1093/aje/kwh101.
Psaty BM: Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture. Circulation. 2010, 121: 940-945. 10.1161/CIRCULATIONAHA.109.933705.
Dehghan A, van Hoek M, Sijbrands EJG, Oostra BA, Hofman A, van Duijn CM, Witteman JCM: Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study. BMC medicine. 2008, 6: 30-10.1186/1741-7015-6-30.
Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP: C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation. 2005, 112: 25-31. 10.1161/CIRCULATIONAHA.104.504159.
Davies RW, Dandona S, Stewart AFR, Chen L, Ellis SG, Tang WHW, Hazen SL, Roberts R, McPherson R, Wells GA: Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circulation. Cardiovascular genetics. 2010, 3: 468-474. 10.1161/CIRCGENETICS.110.946269.